SCHEMBL29601868

SCHEMBL29601868

CN(C(=O)OC(C)(C)C)c1cc(C(F)(F)F)cnc1NC(N)=S

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.39
GAA P10253 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 4/20 0.37
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MAPT P10636 1/20 0.36
NPC1 O15118 1/20 0.36
OPRK1 P41145 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
HPGD P15428 2/20 0.34
ABL1 P00519 1/20 0.34
CACNA1G O43497 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22583484 1.00 ALDH1A1 (0.39) ALDH1A1GAASMN1; SMN2KDM4EKMT2A
SCHEMBL22583092 0.85 ALDH1A1 (0.42) ALDH1A1GAASMN1; SMN2KDM4EKMT2A
SCHEMBL22583033 0.83 KMT2A (0.37) ALDH1A1GAASMN1; SMN2KDM4EKMT2A
SCHEMBL29435582 0.83 KMT2A (0.37) ALDH1A1GAASMN1; SMN2KDM4EKMT2A
SCHEMBL29601685 0.82 MEN1 (0.39) ALDH1A1GAASMN1; SMN2KDM4EKMT2A
SCHEMBL22583490 0.80 CACNA1G (0.34) ALDH1A1KMT2AMEN1L3MBTL1MAPT
SCHEMBL22583020 0.80 ALDH1A1 (0.38) ALDH1A1GAAKDM4EKMT2AMEN1
SCHEMBL29435524 0.80 ALDH1A1 (0.41) ALDH1A1GAASMN1; SMN2KDM4EKMT2A
SCHEMBL22583372 0.80 ALDH1A1 (0.41) ALDH1A1GAASMN1; SMN2KDM4EKMT2A
SCHEMBL29435771 0.78 RAF1 (0.36) ALDH1A1MAPK1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed